Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Big Is The Isosorbide Mononitrate Tablet Market Today And What Is Its Future Size?

The marketplace for isosorbide mononitrate tablets has seen a consistent growth in the past few years. The market is expected to increase from $1.14 billion in 2024 to $1.2 billion in 2025, with a compound annual growth rate (CAGR) of 4.9%. Factors such as the growing number of older people, rising prevalence of heart-related issues, more awareness of cardiac health, the presence of generic drugs, and public health initiatives have all attributed to the growth during the historic period.

Expectations are that the isosorbide mononitrate tablet market will experience robust expansion in the upcoming years, reaching $1.47 billion by 2029 with a compound annual growth rate (CAGR) of 5.3%. The projected growth can be attributed to factors such as regulatory authorizations and patent expiry dates, increased use of generic drugs, a rise in lifestyle-related risk factors, government-led initiatives for cardiovascular disease management, enhanced diagnostic infrastructure, and awareness initiatives. Key trends forecasted for the coming period include progress in extended-release formulations, technological innovations, platforms for digital health and e-commerce, implementation of digital health technologies, and the combination of isosorbide mononitrate with other cardiovascular medicines.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24268&type=smp

Which Demand Drivers Are Strengthening The Isosorbide Mononitrate Tablet Market?

The increasing occurrence of cardiovascular diseases is anticipated to boost the expansion of the isosorbide mononitrate tablet market. These diseases encompass a variety of disorders that affect the heart and blood vessels, such as coronary artery disease, heart failure and hypertension. The primary cause of the escalating occurrence of these diseases is poor dietary habits, which frequently include excessive quantities of saturated fats, trans fats, sodium, and added sugars. This results in health issues like obesity, hypertension, and high cholesterol levels. Isosorbide mononitrate tablets aid in the management of cardiovascular diseases by relaxing and expanding blood vessels. This improves blood circulation and lessens the stress on the heart, thereby relieving chest pain (angina), reducing blood pressure, and facilitating better oxygen delivery to the heart muscle. For example, the Australian Institute of Health and Welfare, a government agency based in Australia, reported in December 2023 that the doctor-certified deaths due to coronary heart disease (CHD) increased to 14,100 in 2021 and further to 14,900 in 2022. Thus, the growing occurrence of cardiovascular diseases is fuelling the growth of the isosorbide mononitrate tablet market.

Which Segment Accounts For The Largest Share In The Isosorbide Mononitrate Tablet Market?

The isosorbide mononitrate tabletmarket covered in this report is segmented –

1) By Dosage Form: Immediate-Release Tablets; Extended-Release Tablets

2) By Indication Type: Angina Pectoris; Heart Failure; Hypertension

3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies

Subsegments:

1) By Immediate-Release Tablets: Low-Dose; Single Strength Tablets; Combination With Other Drugs

2) By Extended-Release Tablets: Moderate-Dose; High-Dose; Once-Daily Formulation; Twice-Daily Formulation

Which Long-Term Trends Will Play A Crucial Role In The Isosorbide Mononitrate Tablet Market?

Key players within the isosorbide mononitrate tablet industry are prioritizing the development of groundbreaking products like extended-release (ER) variations. These are aimed at improving patient adherence, ensuring consistent medicinal effects, and maximizing results for afflictions such as angina pectoris. The extended-release format represents a sophisticated method of drug delivery designed to gradually liberate the medication throughout an extended duration, this ensures a stable level of medication in the bloodstream whilst also minimizing the frequency of dosages. For instance, Zydus Lifesciences Limited, a pharmaceutical manufacturing firm based in India, obtained approval in February 2024 from the United States Food and Drug Administration (USFDA) to produce and distribute isosorbide mononitrate extended-release tablets USP, available in 30 mg, 60 mg, and 120 mg versions. These tablets are designated for the prevention of angina in patients suffering from coronary artery disease, and stand as equivalents to the reference listed drug (RLD), namely imdur extended-release tablets.

Which Companies Hold A Competitive Edge In The 1703 Market?

Major companies operating in the isosorbide mononitrate tablet market are Pfizer Inc., Merck & Co. Inc., AstraZeneca PLC, Abbott Laboratories Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd., Cipla Ltd., Zydus Lifesciences Limited, Recipeharm, Torrent Pharmaceuticals Ltd., Micro Labs Ltd., Lotus Pharmaceuticals, Healthy Inc., Qilu Pharmaceutical Co., Ltd, Lunan Pharmaceutical Group, Johnlee Pharmaceuticals Pvt. Ltd., Niksan Pharmaceutical, Shandong Keyuan Pharmaceutical, Prevego Healthcare & Research Private Limited.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/isosorbide-mononitrate-tablet-global-market-report

Which Region Is Forecasted To Lead The Isosorbide Mononitrate Tablet Market In The Coming Years?

North America was the largest region in the isosorbide mononitrate tablet market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the isosorbide mononitrate tablet market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=24268&type=smp

Browse Through More Reports Similar to the Global Isosorbide Mononitrate Tablet Market 2025, By The Business Research Company

Implantable Heart Pacemaker Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/implantable-heart-pacemaker-global-market-report

Heart Pump Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/heart-pump-devices-global-market-report

Wearable Heart Monitoring Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/wearable-heart-monitoring-devices-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model